Nina S. Kjellson, Director at Ocera Therapeutics, Inc. (OCRX), bought 825,826 shares at $6.03 ($2.6M) on 2013-07-15, disclosed to the SEC on 2013-07-17.
Open-market purchase of $2.6M OCRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 394,391 | $0 | 0.0% |
| 2 | $6.03 | 431,435 | $2.6M | 100.0% |
| Total | $3.15 avg | 825,826 | $2.6M | 100% |
| Filing → |
| TYRA | SELL | 2025-01-21 | $798K | — | Filing → |
| TYRA | SELL | 2024-11-26 | $168K | — | Filing → |
| TYRA | SELL | 2024-11-08 | $2.5M | — | Filing → |